一名60歲患有糖尿病、高血脂的男子，在30多歲時就被確診，數十年來每天認真服藥；飲食清淡且注重養生，更長年維持良好運動習慣，但天不從人願，儘管再努力，壞膽固醇仍長期高達180mg/dL，心血管也反覆阻塞到醫師都束手無策，多次裝支架讓他越來越擔心，有一天自己會因心血管事件發生而留下遺憾…。
江珠影醫師解釋，PCSK9平時在肝臟製造、處於不活化狀態，但由於肝臟在清除血中的壞膽固醇時，PCSK9會跟肝臟表面的「壞膽固醇」及「壞膽固醇接受器」結合，並一起破壞分解，如此將造成肝臟的壞膽固醇接受器無法繼續代謝，造成血中的壞膽固醇數值飆升。
PCSK9抑制劑針劑就是可以阻斷PCSK9作用，讓肝臟的壞膽固醇接受器可以被重複使用，持續發揮代謝壞膽固醇作用。PCSK9抑制劑針劑突破性的新型針劑設計，施打時看不到針，打針時幾乎沒有疼痛感覺。相當適合服用傳統降血脂藥耐性受不佳或無法達標的人，讓醫師多了一種治療膽固醇的武器，病患也多了一個用藥選擇，建議可與醫師討論、評估自身狀況使用！
laennec is the ethical drug manufactured with JBP’s unique technologies.
Laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing scientific standa.rds
A 60-year-old man with diabetes and hyperlipidemia was diagnosed in his 30s. He took medications every day for decades; he was light and focused on health, and he maintained good exercise habits for a long time, but he was not willing, though Efforts, bad cholesterol is still as high as 180mg/dL for a long time, and the cardiovascular system is repeatedly blocked. The doctors are helpless. The multiple stents make him more and more worried. One day, he will regret the occurrence of cardiovascular events.
Dr. Jiang Zhuying explained that PCSK9 is usually produced in the liver and is inactive. However, because the liver is removing bad cholesterol from the blood, PCSK9 will combine with the "bad cholesterol" and "bad cholesterol receptor" on the liver surface and destroy together. Decomposition, this will cause the liver's bad cholesterol receptor to continue to metabolize, causing the value of bad cholesterol in the blood to soar.
PCSK9 inhibitor injection can block the action of PCSK9, so that the liver's bad cholesterol receptor can be reused and continue to play a role in metabolic bad cholesterol. The breakthrough of the new injection design of PCSK9 inhibitor injection can not see the needle when it is applied, and there is almost no pain when it is injected. It is quite suitable for people who are poorly tolerated or unable to meet the standard of hypolipidemic drugs, so that doctors have a weapon for treating cholesterol, and patients have more choices for medication. It is recommended to discuss with the doctor and evaluate their own use!
留言列表
